Font:
EM

EMCURE / NSE / Biotechnology & Drugs

Emcure Pharmaceuticals

INR 1,826.790.50 (0.51%) 1D
Last updated: 2026-06-15T19:20:14.422412+00:00
Price Chart

1Y Price Trend

Open1,362.2
High1,830
Low1,228.9
Close1,705.6
Volume2,85,086
Change343.4
Change %25.21%

Key Information

Ticker SymbolEMCURE
Current Price1,826.7
52-Week High1,944
52-Week Low1,237
Market Cap34,600.51
Volume2,85,086
ISININE168P01015
Day High1,738.8
Day Low1,681
Open1,732.9

Recommendations

RatingStrong Buy

Target High1,944

Target Low1,230

Target Mean1.33

Target Median41.67

Risk Metrics

Overall RiskBalanced risk

Board Risk34.98

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

'Don't You Read Orders?': Delhi HC Fines Emcure ₹10,000 Over Duplicate Court Fee Refund Plea In Trademark ... - LiveLawBiz3 days ago
Market news

'Don't You Read Orders?': Delhi HC Fines Emcure ₹10,000 Over Duplicate Court Fee Refund Plea In Trademark ... LiveLawBiz

Emcure Unit Marcan to Acquire Remaining Stake in Canada's Mantra Pharma for CAD 50 Million - Medical Dialogues4 days ago
Market news

Emcure Unit Marcan to Acquire Remaining Stake in Canada's Mantra Pharma for CAD 50 Million Medical Dialogues

Emcure unit acquires Mantra Pharma shares for CAD 50 million - scanx.trade5 days ago
Market news

Emcure unit acquires Mantra Pharma shares for CAD 50 million scanx.trade

Emcure Pharma Unit Acquires 100% Stake In Canada’s Mantra Pharma For ₹336 Crore - Sahi6 days ago
Market news

Emcure Pharma Unit Acquires 100% Stake In Canada’s Mantra Pharma For ₹336 Crore Sahi

Emcure Pharmaceuticals President Kuber Jagdale superannuates - scanx.trade8 days ago
Market news

Emcure Pharmaceuticals President Kuber Jagdale superannuates scanx.trade

Enterprise value to EBIT forward of Emcure Pharmaceuticals Limited – NSE:EMCURE - TradingView12 days ago
Market news

Enterprise value to EBIT forward of Emcure Pharmaceuticals Limited – NSE:EMCURE TradingView

Price to sales forward of Emcure Pharmaceuticals Limited – NSE:EMCURE - TradingView13 days ago
Market news

Price to sales forward of Emcure Pharmaceuticals Limited – NSE:EMCURE TradingView

Bain Capital Sells 1.02% Stake in Emcure for ₹352 Cr - outlookbusiness.com13 days ago
Market news

Bain Capital Sells 1.02% Stake in Emcure for ₹352 Cr outlookbusiness.com

FAQ

Stock FAQs

What is the NSE symbol for Emcure Pharmaceuticals?

Emcure Pharmaceuticals trades on NSE with the symbol EMCURE. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Emcure Pharmaceuticals share price and chart?

You can track Emcure Pharmaceuticals share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Emcure Pharmaceuticals?

Yes. ShareKeyX displays available financial statements for Emcure Pharmaceuticals using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Emcure Pharmaceuticals?

Yes. ShareKeyX displays available historical OHLC candles for Emcure Pharmaceuticals across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Emcure Pharmaceuticals belong to?

Emcure Pharmaceuticals is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Emcure Pharmaceuticals?

Yes. ShareKeyX shows the latest available stock news for Emcure Pharmaceuticals from the connected stock news source.